NEURO-ONCOLOGY IN 2013 Improving outcome in newly diagnosed malignant glioma

被引：18

作者：

Weller, Michael ^{[1
,2
]}

Wick, Wolfgang ^{[3
,4
]}

机构：

[1] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland

[2] Univ Zurich Hosp, Brain Tumour Ctr, CH-8091 Zurich, Switzerland

[3] Univ Heidelberg Hosp, Neurol Clin, Dept Neurooncol, D-69120 Heidelberg, Germany

[4] Univ Heidelberg Hosp, Natl Ctr Tumour Dis, D-69120 Heidelberg, Germany

来源：

NATURE REVIEWS NEUROLOGY | 2014年 / 10卷 / 02期

关键词：

GLIOBLASTOMA;

D O I：

10.1038/nrneurol.2013.268

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

In 2013, two discoveries-that alkylating agent chemotherapy prolongs survival when added to radiotherapy for patients with anaplastic oligodendroglial tumours with 1p19q codeletion, and that bevacizumab prolongs progression-free survival in patients with newly diagnosed glioblastoma-have dominated debate in neuro-oncology. These findings could help to define new standards of care in malignant glioma.

引用

页码：68 / 70

页数：4

共 10 条

[1] The Somatic Genomic Landscape of Glioblastoma [J].

Brennan, Cameron W. ;

Verhaak, Roel G. W. ;

McKenna, Aaron ;

Campos, Benito ;

Noushmehr, Houtan ;

Salama, Sofie R. ;

Zheng, Siyuan ;

Chakravarty, Debyani ;

Sanborn, J. Zachary ;

Berman, Samuel H. ;

Beroukhim, Rameen ;

Bernard, Brady ;

Wu, Chang-Jiun ;

Genovese, Giannicola ;

Shmulevich, Ilya ;

Barnholtz-Sloan, Jill ;

Zou, Lihua ;

Vegesna, Rahulsimham ;

Shukla, Sachet A. ;

Ciriello, Giovanni ;

Yung, W. K. ;

Zhang, Wei ;

Sougnez, Carrie ;

Mikkelsen, Tom ;

Aldape, Kenneth ;

Bigner, Darell D. ;

Van Meir, Erwin G. ;

Prados, Michael ;

Sloan, Andrew ;

Black, Keith L. ;

Eschbacher, Jennifer ;

Finocchiaro, Gaetano ;

Friedman, William ;

Andrews, David W. ;

Guha, Abhijit ;

Iacocca, Mary ;

O'Neill, Brian P. ;

Foltz, Greg ;

Myers, Jerome ;

Weisenberger, Daniel J. ;

Penny, Robert ;

Kucherlapati, Raju ;

Perou, Charles M. ;

Hayes, D. Neil ;

Gibbs, Richard ;

Marra, Marco ;

Mills, Gordon B. ;

Lander, Eric ;

Spellman, Paul ;

Wilson, Richard .

CELL, 2013, 155 (02) :462-477

[2] Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 [J].

Cairncross, Gregory ;

Wang, Meihua ;

Shaw, Edward ;

Jenkins, Robert ;

Brachman, David ;

Buckner, Jan ;

Fink, Karen ;

Souhami, Luis ;

Laperriere, Normand ;

Curran, Walter ;

Mehta, Minesh .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :337-343

[3]

Chinot O, N ENGL J ME IN PRESS

[4]

Gilbert MR, N ENGL J ME IN PRESS

[5] Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma [J].

Sturm, Dominik ;

Witt, Hendrik ;

Hovestadt, Volker ;

Dong-Anh Khuong-Quang ;

Jones, David T. W. ;

Konermann, Carolin ;

Pfaff, Elke ;

Toenjes, Marge ;

Sill, Martin ;

Bender, Sebastian ;

Kool, Marcel ;

Zapatka, Marc ;

Becker, Natalia ;

Zucknick, Manuela ;

Hielscher, Thomas ;

Liu, Xiao-Yang ;

Fontebasso, Adam M. ;

Ryzhova, Marina ;

Albrecht, Steffen ;

Jacob, Karine ;

Wolter, Marietta ;

Ebinger, Martin ;

Schuhmann, Martin U. ;

van Meter, Timothy ;

Fruehwald, Michael C. ;

Hauch, Holger ;

Pekrun, Arnulf ;

Radlwimmer, Bernhard ;

Niehues, Tim ;

von Komorowski, Gregor ;

Duerken, Matthias ;

Kulozik, Andreas E. ;

Madden, Jenny ;

Donson, Andrew ;

Foreman, Nicholas K. ;

Drissi, Rachid ;

Fouladi, Maryam ;

Scheurlen, Wolfram ;

von Deimling, Andreas ;

Monoranu, Camelia ;

Roggendorf, Wolfgang ;

Herold-Mende, Christel ;

Unterberg, Andreas ;

Kramm, Christof M. ;

Felsberg, Joerg ;

Hartmann, Christian ;

Wiestler, Benedikt ;

Wick, Wolfgang ;

Milde, Till ;

Witt, Olaf .

CANCER CELL, 2012, 22 (04) :425-437

[6] Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 [J].

van den Bent, Martin J. ;

Brandes, Alba A. ;

Taphoorn, Martin J. B. ;

Kros, Johan M. ;

Kouwenhoven, Mathilde C. M. ;

Delattre, Jean-Yves ;

Bernsen, Hans J. J. A. ;

Frenay, Marc ;

Tijssen, Cees C. ;

Grisold, Wolfgang ;

Sipos, Laszlo ;

Enting, Roelien H. ;

French, Pim J. ;

Dinjens, Winand N. M. ;

Vecht, Charles J. ;

Allgeier, Anouk ;

Lacombe, Denis ;

Gorlia, Thierry ;

Hoang-Xuan, Khe .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :344-350

[7] Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab [J].

Wefel, Jeffrey S. ;

Cloughesy, Timothy ;

Zazzali, James L. ;

Zheng, Maoxia ;

Prados, Michael ;

Wen, Patrick Y. ;

Mikkelsen, Tom ;

Schiff, David ;

Abrey, Lauren E. ;

Yung, W. K. Alfred ;

Paleologos, Nina ;

Nicholas, Martin K. ;

Jensen, Randy ;

Vredenburgh, James ;

Das, Asha ;

Friedman, Henry S. .

NEURO-ONCOLOGY, 2011, 13 (06) :660-668

[8] Molecular neuro-oncology in clinical practice: a new horizon [J].

Weller, Michael ;

Pfister, Stefan M. ;

Wick, Wolfgang ;

Hegi, Monika E. ;

Reifenberger, Guido ;

Stupp, Roger .

LANCET ONCOLOGY, 2013, 14 (09) :E370-E379

[9] Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation [J].

Wick, Wolfgang ;

Meisner, Christoph ;

Hentschel, Bettina ;

Platten, Michael ;

Schilling, Alissa ;

Wiestler, Benedikt ;

Sabel, Michael C. ;

Koeppen, Susanne ;

Ketter, Ralf ;

Weiler, Markus ;

Tabatabai, Ghazaleh ;

von Deimling, Andreas ;

Gramatzki, Dorothee ;

Westphal, Manfred ;

Schackert, Gabriele ;

Loeffler, Markus ;

Simon, Matthias ;

Reifenberger, Guido ;

Weller, Michael .

NEUROLOGY, 2013, 81 (17) :1515-1522

[10] NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide [J].

Wick, Wolfgang ;

Hartmann, Christian ;

Engel, Corinna ;

Stoffels, Mandy ;

Felsberg, Joerg ;

Stockhammer, Florian ;

Sabel, Michael C. ;

Koeppen, Susanne ;

Ketter, Ralf ;

Meyermann, Richard ;

Rapp, Marion ;

Meisner, Christof ;

Kortmann, Rolf D. ;

Pietsch, Torsten ;

Wiestler, Otmar D. ;

Ernemann, Ulrike ;

Bamberg, Michael ;

Reifenberger, Guido ;

von Deimling, Andreas ;

Weller, Michael .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) :5874-5880

← 1 →